Abstract
Three groups of weanling male rats were reared on a fat-free diet for 13 weeks. One group received only the fat-free diet (FF rats), the other 2 groups received the fat-free diet and a daily supplement of 2 energy% ethyl linoleate ([n−6] rats), or 2 energy% ethyl linolenate ([n−3] rats). The chopped lung preparation was used to illustrate an in vitro prostaglandin formation. PGE2-like activity was quantified on rat stomach strip. The release of PGE2-like activity expressed as ng PGE2-equivalent per g lung tissue (mean±SD) was 23±7, <6, and 65±20 for the FF rats, the (n−3) rats, and the (n−6) rats, respectively. PGE2 quantification by radioimmunoassay of the chopped lung effluent collected after passing over the rat stomach strip revealed the same release pattern as the bioassay. Fractionation of chopped lung effluent on HPLC with radioimmunoassay detection indicated that the lung tissue from (n−3) rats released very little PGE3, if any, in spite of a 20∶5(n−3)/20∶4(n−6) ratio of 5.2 in the lipids of the lung. It is suggested that the pool of arachidonic acid for prostaglandin production in vitro is different from the one which functions in vivo, and that these pools are differently affected by dietary EFA.
Similar content being viewed by others
Abbreviations
- EFA:
-
essential fatty acid
- PGE2, PGE3 :
-
prostaglandin E2, prostaglandin E3, etc.
- HPLC:
-
high performance liquid chromatography
- RIA:
-
radioimmunoassay
References
Mathias, M.M., and Dupont, J. (1979) Lipids 14, 247–252.
ten Hoor, F., de Deckere, E.A.M., Haddeman, E., Hornstra, G., and Quadt, J.F.A. (1980) Adv. Prostagl. Thrombox. Res. 8, 1771–1781.
Mohrhauer, H., and Holman, R.T. (1963) J. Nutr. 81, 67–74.
Struijk, C.B., Beerthuis, R.K., Pabon, H.J.J., and van Dorp, D.A. (1966) Recl. Trav. Chim. 85, 1233–1250.
Smith, D.R., Weatherly, B.C., Salmon, J.A., Ubatuba, F.B., Gryglewski, R.J., and Moncada, S. (1979) Prostaglandins 18, 423–438.
Lands, W.E.M., LeTellier, P.R., Rome, L.H., and Vanderhoek, J.V. (1973) Adv. Biosci. 9, 15–28.
Ramwell, P.W., and Shaw, J.E. (1970) Recent Progr. Hormone Res. 26, 139–187.
Schwartzman, M., and Raz, A. (1982) Biochem. Pharmacol. 31, 2453–2458.
Hansen, H.S. (1983) World Rev. Nutr. Dietetics (in press).
Hansen, H.S., and Jensen, B. (1983) Lipids 18, xxx-xxx.
Fjalland, B. (1974) J. Pharm. Pharmac. 26, 448–451.
Gilmore, N., Vane, J.R., and Wyllie, J.H. (1968) Nature 218, 1135–1140.
Vane, J.R. (1957) Br. J. Pharmacol. 12, 344–349.
Christensen, P., and Leyssac, P.P. (1976) Prostaglandins 11, 399–420.
Hansen, H.S. (1981) Lipids 16, 849–854.
Powell, W.S. (1982) Methods Enzymol. 86, 467–477.
Ferretti, A., Schoene, N.W., and Flanagan, V.P. (1981) Lipids 16, 800–804.
Schoene, N.W., Ferretti, A., and Fiore, D. (1981) Lipids 16, 866–869.
Smith, W.L. (1981) Mineral. Electrolyte Metab. 6, 10–20.
Granström, E., and Samuelsson, B. (1978) Adv. Prostagl. Thrombox. Res. 5, 1–13.
Author information
Authors and Affiliations
About this article
Cite this article
Hansen, H.S., Fjalland, B. & Jensen, B. Extremely decreased release of prostaglandin E2-like activity from chopped lung of ethyl linolenate-supplemented rats. Lipids 18, 691–695 (1983). https://doi.org/10.1007/BF02534535
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02534535